Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Preferred Stock Liabilities: 2019-2021

Historic Preferred Stock Liabilities for P3 Health Partners (PIII) over the last 3 years, with FY2021 value amounting to $47.0 million.

  • P3 Health Partners' Preferred Stock Liabilities changed N/A to $47.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $47.0 million, marking a year-over-year change of. This contributed to the annual value of $47.0 million for FY2021, which is N/A changed from last year.
  • Latest data reveals that P3 Health Partners reported Preferred Stock Liabilities of $47.0 million as of FY2021.
  • Over the past 5 years, P3 Health Partners' Preferred Stock Liabilities peaked at $51.6 million during FY2020, and registered a low of $47.0 million during FY2021.
  • Its 3-year average for Preferred Stock Liabilities is $48.7 million, with a median of $47.6 million in 2019.
  • The largest annual percentage gain for P3 Health Partners' Preferred Stock Liabilities in the last 5 years was 852.1% (2020), contrasted with its biggest fall of 852.1% (2020).
  • Over the past 3 years, P3 Health Partners' Preferred Stock Liabilities (Annual) stood at $47.6 million in 2019, then rose by 8.52% to $51.6 million in 2020, then decreased by 8.85% to $47.0 million in 2021.
  • Its Preferred Stock Liabilities stands at $47.0 million for FY2021, versus $51.6 million for FY2020 and $47.6 million for FY2019.